Because our products are designed and built with system integration in mind, no matter which type of oral solid dosage (OSD) form you need to produce, we can help you to select the optimal solution.
By embracing digitalization, modularization, holistic product innovation and sustainability, we can supply both standard and custom-configured lines to suit specific projects. For example, fluid bed dryers and coaters can be combined with top- or bottom-drive high shear mixer/granulators, wet and dry milling facilities, product handling systems, binder and coating preparation units, filtration units and/or tablet presses. Furthermore, safety, containment, product flow and building requirements are fully incorporated for optimum process efficiency.
With a stronger focus on efficiency, Industry 4.0 and the environment, the pharmaceutical industry is evolving. GEA is committed to transforming tomorrow with better processes and has enthusiastically embraced these themes. For example, when the industry embraced continuous manufacturing to improve efficiencies and product quality, GEA was already bringing process-ready technology to the market.
And when it comes to digitalization, we’ve been innovating for years and bringing new services to customers, such as our virtual reality (VR)-based training modules. Ongoing product innovation, making our equipment better for the user and the planet, ensures that when you invest in a GEA process line, you’re making the right choice.
Отображение 4 из 27
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Powder Talks - Aseptic Spray Drying
Когда южнокорейский производитель продуктов питания из растительного сырья Pulmuone поставил перед компанией GEA задачу разработать современный вариант традиционной холодной тягучей лапши (нэнмён), специалисты GEA по исследованиям и разработкам успешно справились с этой задачей. GEA помогла разработать продукт, который сейчас является коммерческим хитом и производится с меньшими затратами воды и электроэнергии, чем с использованием ранее существовавших методов. Результат соответствует традиционному характеру блюда, а также принципам поддержания здоровья, благополучия и устойчивого развития компании Pulmuone.
Инновационный процесс компании GEA является важной вехой в предварительной очистке такого биотоплива, как гидроочищенное растительное масло и экологически чистое авиационное топливо. Благодаря отказу от процесса отбеливания производители получают значительную экономию через снижение эксплуатационных расходов более чем на 50% и сокращение выбросов CO2 на 12%.